3u7w
From Proteopedia
(Difference between revisions)
| Line 3: | Line 3: | ||
<StructureSection load='3u7w' size='340' side='right'caption='[[3u7w]], [[Resolution|resolution]] 2.60Å' scene=''> | <StructureSection load='3u7w' size='340' side='right'caption='[[3u7w]], [[Resolution|resolution]] 2.60Å' scene=''> | ||
== Structural highlights == | == Structural highlights == | ||
| - | <table><tr><td colspan='2'>[[3u7w]] is a 2 chain structure with sequence from [https://en.wikipedia.org/wiki/ | + | <table><tr><td colspan='2'>[[3u7w]] is a 2 chain structure with sequence from [https://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=3U7W OCA]. For a <b>guided tour on the structure components</b> use [https://proteopedia.org/fgij/fg.htm?mol=3U7W FirstGlance]. <br> |
| - | </td></tr><tr id=' | + | </td></tr><tr id='method'><td class="sblockLbl"><b>[[Empirical_models|Method:]]</b></td><td class="sblockDat" id="methodDat">X-ray diffraction, [[Resolution|Resolution]] 2.6Å</td></tr> |
| - | <tr id=' | + | <tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat" id="ligandDat"><scene name='pdbligand=GOL:GLYCEROL'>GOL</scene>, <scene name='pdbligand=NAG:N-ACETYL-D-GLUCOSAMINE'>NAG</scene>, <scene name='pdbligand=PCA:PYROGLUTAMIC+ACID'>PCA</scene>, <scene name='pdbligand=SO4:SULFATE+ION'>SO4</scene></td></tr> |
| - | + | ||
| - | + | ||
<tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[https://proteopedia.org/fgij/fg.htm?mol=3u7w FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=3u7w OCA], [https://pdbe.org/3u7w PDBe], [https://www.rcsb.org/pdb/explore.do?structureId=3u7w RCSB], [https://www.ebi.ac.uk/pdbsum/3u7w PDBsum], [https://prosat.h-its.org/prosat/prosatexe?pdbcode=3u7w ProSAT]</span></td></tr> | <tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[https://proteopedia.org/fgij/fg.htm?mol=3u7w FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=3u7w OCA], [https://pdbe.org/3u7w PDBe], [https://www.rcsb.org/pdb/explore.do?structureId=3u7w RCSB], [https://www.ebi.ac.uk/pdbsum/3u7w PDBsum], [https://prosat.h-its.org/prosat/prosatexe?pdbcode=3u7w ProSAT]</span></td></tr> | ||
</table> | </table> | ||
| - | + | == Disease == | |
| - | = | + | [https://www.uniprot.org/uniprot/IGHG1_HUMAN IGHG1_HUMAN] Defects in IGHG1 are a cause of multiple myeloma (MM) [MIM:[https://omim.org/entry/254500 254500]. MM is a malignant tumor of plasma cells usually arising in the bone marrow and characterized by diffuse involvement of the skeletal system, hyperglobulinemia, Bence-Jones proteinuria and anemia. Complications of multiple myeloma are bone pain, hypercalcemia, renal failure and spinal cord compression. The aberrant antibodies that are produced lead to impaired humoral immunity and patients have a high prevalence of infection. Amyloidosis may develop in some patients. Multiple myeloma is part of a spectrum of diseases ranging from monoclonal gammopathy of unknown significance (MGUS) to plasma cell leukemia. Note=A chromosomal aberration involving IGHG1 is found in multiple myeloma. Translocation t(11;14)(q13;q32) with the IgH locus. Translocation t(11;14)(q13;q32) with CCND1; translocation t(4;14)(p16.3;q32.3) with FGFR3; translocation t(6;14)(p25;q32) with IRF4. |
| - | + | == Function == | |
| - | + | [https://www.uniprot.org/uniprot/IGHG1_HUMAN IGHG1_HUMAN] | |
| - | + | ||
| - | + | ||
| - | + | ||
| - | + | ||
| - | + | ||
| - | == | + | |
| - | + | ||
__TOC__ | __TOC__ | ||
</StructureSection> | </StructureSection> | ||
| - | [[Category: | + | [[Category: Homo sapiens]] |
[[Category: Large Structures]] | [[Category: Large Structures]] | ||
| - | [[Category: Bjorkman | + | [[Category: Bjorkman PJ]] |
| - | [[Category: Diskin | + | [[Category: Diskin R]] |
| - | + | ||
| - | + | ||
| - | + | ||
| - | + | ||
Revision as of 13:50, 14 March 2024
Crystal structure of NIH45-46 Fab
| |||||||||||
